Abstract
Pathologic conditions of the upper airway have been shown to influence pathologic conditions and function of the lower airway, leading to development of the unified airway model as reviewed by Krouse et al.1 Demonstrations of the unified airway model have been most valid in allergic rhinitis and chronic rhinosinusitis and their respective effects on asthma. Topical corticosteroids2,3 and subcutaneous immunotherapy4 for allergic rhinitis have been shown to decrease asthma symptoms, reduce bronchiolar reactivity, and improve performance on pulmonary function tests (PFTs). Similarly, medical5 and surgical6,7 treatment in the case of chronic rhinosinusitis improves asthma symptoms or pulmonary function.

This publication has 21 references indexed in Scilit: